Items where Author is "Mathieu, MG"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 10.

Journal article

Harner-Foreman, N, Vadakekolathu, J, Laversin, SA, Mathieu, MG, Reeder, S, Pockley, AG ORCID: 0000-0001-9593-6431, Rees, RC and Boocock, DJ ORCID: 0000-0002-7333-3549, 2017. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics. Scientific Reports, 7, p. 40633. ISSN 2045-2322

Mathieu, MG, Miles, AK, Ahmad, M, Buczek, ME, Pockley, AG, Rees, RC and Regad, T ORCID: 0000-0003-4028-6368, 2014. The helicase HAGE prevents interferon-a-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death and Disease, 5 (2). ISSN 2041-4889

Mathieu, MG, Miles, AK ORCID: 0000-0002-5388-938X, Ahmad, M, Buczek, ME, Pockley, AG ORCID: 0000-0001-9593-6431, Rees, RC and Regad, T ORCID: 0000-0003-4028-6368, 2014. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death & Disease, 5 (2). ISSN 2041-4889

Linley, AJ, Mathieu, MG, Miles, AK, Rees, RC, McArdle, SEB and Regad, T ORCID: 0000-0003-4028-6368, 2012. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tunor cell proliferation in vivo. Journal of Biological Chemistry, 287 (17), pp. 13633-13643.

Mathieu, MG, Linley, AJ, Reeder, SP, Badoual, C, Tartour, E, Rees, RC and McArdle, SEB ORCID: 0000-0001-6929-9782, 2010. HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers. Cancer Immunity, 10, p. 2.

Linley, AJ, Miles, AK ORCID: 0000-0002-5388-938X, Al-Fawaz, M, Lu, C ORCID: 0000-0002-0064-4725, McArdle, SEB ORCID: 0000-0001-6929-9782, Rees, RC and Mathieu, MG, 2009. Non-X-linked cancer/testis antigens: identification, expression profile and immunogenicity [review]. Current Trends in Immunology.

Riley, CL, Mathieu, MG, Clark, RE, McArdle, SE ORCID: 0000-0001-6929-9782 and Rees, RC, 2009. Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable? Cancer Immunology Immunotherapy, 58 (9), pp. 1489-1499.

Mathieu, MG, Knights, AJ, Pawelec, G, Riley, CL, Wernet, D, Lemonnier, FA, Straten, PT, Mueller, L, Rees, RC and Mcardle, SE, 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004

Assudani, DP, Horton, RBV, Mathieu, MG, Mcardle, SE ORCID: 0000-0001-6929-9782 and Rees, RC, 2007. The role of CD4(+) T cell help in cancer immunity and the formulation of novel cancer vaccines. Cancer Immunology Immunotherapy, 56 (1), pp. 70-80. ISSN 0340-7004

Chapter in book

Regad, T ORCID: 0000-0003-4028-6368 and Mathieu, MG, 2014. Cancer Stem Cells (CSCs) and Epithelial-to-Mesenchymal Transition (EMT): tumor cell plasticity challenges immunotherapy. In: Rees, RC, ed., Tumor immunology and immunotherapy. Oxford: Oxford University Press. ISBN 9780199676866

This list was generated on Tue Sep 26 12:56:53 2017 UTC.